Jiangsu Hengrui Medicine Co Ltd (600276) — Cash Flow-to-Debt Ratio
Jiangsu Hengrui Medicine Co Ltd (600276) has a Cash Flow-to-Debt Ratio of 0.58x as of September 2025, meaning its operating cash flow of CN¥4.81 Billion could theoretically repay 1% of its total liabilities (CN¥8.30 Billion) in one year. See Jiangsu Hengrui Medicine Co Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Jiangsu Hengrui Medicine Co Ltd Cash Flow-to-Debt Ratio (1999–2024)
Historical debt coverage capacity for Jiangsu Hengrui Medicine Co Ltd across 26 annual periods. Also explore Jiangsu Hengrui Medicine Co Ltd net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Jiangsu Hengrui Medicine Co Ltd (1999–2024)
Year-by-year debt coverage analysis for Jiangsu Hengrui Medicine Co Ltd. For market capitalisation and broader financial context, see Jiangsu Hengrui Medicine Co Ltd market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 1.83x | CN¥7.42 Billion | CN¥4.05 Billion | ▼ -34.0% |
| 2023 | 2.78x | CN¥7.64 Billion | CN¥2.75 Billion | ▲ +765.5% |
| 2022 | 0.32x | CN¥1.27 Billion | CN¥3.94 Billion | ▼ -71.9% |
| 2021 | 1.14x | CN¥4.22 Billion | CN¥3.69 Billion | ▲ +31.2% |
| 2020 | 0.87x | CN¥3.43 Billion | CN¥3.94 Billion | ▼ -40.3% |
| 2019 | 1.46x | CN¥3.82 Billion | CN¥2.62 Billion | ▲ +34.7% |
| 2018 | 1.08x | CN¥2.77 Billion | CN¥2.56 Billion | ▼ -10.9% |
| 2017 | 1.22x | CN¥2.55 Billion | CN¥2.10 Billion | ▼ -31.8% |
| 2016 | 1.78x | CN¥2.59 Billion | CN¥1.46 Billion | ▼ -10.9% |
| 2015 | 2.00x | CN¥2.28 Billion | CN¥1.14 Billion | ▲ +1.2% |
| 2014 | 1.98x | CN¥1.57 Billion | CN¥796.98 Million | ▼ -18.3% |
| 2013 | 2.42x | CN¥1.36 Billion | CN¥564.40 Million | ▲ +13.6% |
| 2012 | 2.13x | CN¥958.37 Million | CN¥450.01 Million | ▲ +77.5% |
| 2011 | 1.20x | CN¥527.36 Million | CN¥439.47 Million | ▲ +30.8% |
| 2010 | 0.92x | CN¥385.95 Million | CN¥420.80 Million | ▼ -30.3% |
| 2009 | 1.32x | CN¥439.12 Million | CN¥333.85 Million | ▲ +157.5% |
| 2008 | 0.51x | CN¥117.46 Million | CN¥229.91 Million | ▼ -11.2% |
| 2007 | 0.58x | CN¥218.87 Million | CN¥380.51 Million | ▼ -56.5% |
| 2006 | 1.32x | CN¥266.18 Million | CN¥201.07 Million | ▲ +2.9% |
| 2005 | 1.29x | CN¥227.88 Million | CN¥177.10 Million | ▲ +58.1% |
| 2004 | 0.81x | CN¥209.41 Million | CN¥257.33 Million | ▲ +225.6% |
| 2003 | 0.25x | CN¥136.82 Million | CN¥547.34 Million | ▲ +97.9% |
| 2002 | 0.13x | CN¥49.84 Million | CN¥394.60 Million | ▲ +296.9% |
| 2001 | 0.03x | CN¥11.49 Million | CN¥361.03 Million | ▼ -49.1% |
| 2000 | 0.06x | CN¥19.61 Million | CN¥313.71 Million | ▼ -44.5% |
| 1999 | 0.11x | CN¥33.89 Million | CN¥301.17 Million | — |